 | • レポートコード：GIR-22F19364 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Graves Disease Treatment Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界のバセドウ病治療の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 バセドウ病治療市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・抗甲状腺薬、放射性ヨウ素療法 アプリケーション別セグメントは次のように区分されます。 ・病院 調剤薬局、総合調剤薬局 世界のバセドウ病治療市場の主要な市場プレーヤーは以下のとおりです。 ・Abbott、GlaxoSmithKline plc、Merck & Co、Pfizer, Inc、RLC LABS、AbbVie, Inc、Mylan N.V、Allergan, plc、Novartis AG、Apitope、Amgen INC.、Sun Pharmaceuticals Industries LTD、Immunovant Inc 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、バセドウ病治療製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なバセドウ病治療メーカーの企業概要、2019年～2022年までのバセドウ病治療の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なバセドウ病治療メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別バセドウ病治療の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのバセドウ病治療のタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのバセドウ病治療市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびバセドウ病治療の産業チェーンを掲載しています。 ・第13、14、15章では、バセドウ病治療の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - バセドウ病治療の概要 - タイプ別分析（2017年vs2021年vs2028年）：抗甲状腺薬、放射性ヨウ素療法 - アプリケーション別分析（2017年vs2021年vs2028年）：病院 調剤薬局、総合調剤薬局 - 世界のバセドウ病治療市場規模・予測 - 世界のバセドウ病治療生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Abbott、GlaxoSmithKline plc、Merck & Co、Pfizer, Inc、RLC LABS、AbbVie, Inc、Mylan N.V、Allergan, plc、Novartis AG、Apitope、Amgen INC.、Sun Pharmaceuticals Industries LTD、Immunovant Inc ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：抗甲状腺薬、放射性ヨウ素療法 ・アプリケーション別分析2017年-2028年：病院 調剤薬局、総合調剤薬局 ・バセドウ病治療の北米市場分析 - バセドウ病治療の北米市場：タイプ別市場規模2017年-2028年 - バセドウ病治療の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・バセドウ病治療のヨーロッパ市場分析 - ：バセドウ病治療のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：バセドウ病治療のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・バセドウ病治療のアジア太平洋市場分析 - バセドウ病治療のアジア太平洋市場：タイプ別市場規模2017年-2028年 - バセドウ病治療のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・バセドウ病治療の南米市場分析 - バセドウ病治療の南米市場：タイプ別市場規模2017年-2028年 - バセドウ病治療の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・バセドウ病治療の中東・アフリカ市場分析 - バセドウ病治療の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - バセドウ病治療の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Graves Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Graves Disease Treatment market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospitals Pharmacies accounting for % of the Graves Disease Treatment global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Anti-Thyroid Medication segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Graves Disease Treatment include Abbott, GlaxoSmithKline plc, Merck & Co, Pfizer, Inc, and RLC LABS, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Graves Disease Treatment market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Anti-Thyroid Medication
Radioactive Iodine Therapy
Market segment by Application can be divided into
Hospitals Pharmacies
Retail Pharmacies
The key market players for global Graves Disease Treatment market are listed below:
Abbott
GlaxoSmithKline plc
Merck & Co
Pfizer, Inc
RLC LABS
AbbVie, Inc
Mylan N.V
Allergan, plc
Novartis AG
Apitope
Amgen INC.
Sun Pharmaceuticals Industries LTD
Immunovant Inc
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Graves Disease Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Graves Disease Treatment, with price, sales, revenue and global market share of Graves Disease Treatment from 2019 to 2022.
Chapter 3, the Graves Disease Treatment competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Graves Disease Treatment breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Graves Disease Treatment market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Graves Disease Treatment.
Chapter 13, 14, and 15, to describe Graves Disease Treatment sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Graves Disease Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Graves Disease Treatment Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Anti-Thyroid Medication
1.2.3 Radioactive Iodine Therapy
1.3 Market Analysis by Application
1.3.1 Overview: Global Graves Disease Treatment Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.4 Global Graves Disease Treatment Market Size & Forecast
1.4.1 Global Graves Disease Treatment Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Graves Disease Treatment Sales in Volume (2017-2028)
1.4.3 Global Graves Disease Treatment Price (2017-2028)
1.5 Global Graves Disease Treatment Production Capacity Analysis
1.5.1 Global Graves Disease Treatment Total Production Capacity (2017-2028)
1.5.2 Global Graves Disease Treatment Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Graves Disease Treatment Market Drivers
1.6.2 Graves Disease Treatment Market Restraints
1.6.3 Graves Disease Treatment Trends Analysis
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Graves Disease Treatment Product and Services
2.1.4 Abbott Graves Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GlaxoSmithKline plc
2.2.1 GlaxoSmithKline plc Details
2.2.2 GlaxoSmithKline plc Major Business
2.2.3 GlaxoSmithKline plc Graves Disease Treatment Product and Services
2.2.4 GlaxoSmithKline plc Graves Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Merck & Co
2.3.1 Merck & Co Details
2.3.2 Merck & Co Major Business
2.3.3 Merck & Co Graves Disease Treatment Product and Services
2.3.4 Merck & Co Graves Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Pfizer, Inc
2.4.1 Pfizer, Inc Details
2.4.2 Pfizer, Inc Major Business
2.4.3 Pfizer, Inc Graves Disease Treatment Product and Services
2.4.4 Pfizer, Inc Graves Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 RLC LABS
2.5.1 RLC LABS Details
2.5.2 RLC LABS Major Business
2.5.3 RLC LABS Graves Disease Treatment Product and Services
2.5.4 RLC LABS Graves Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 AbbVie, Inc
2.6.1 AbbVie, Inc Details
2.6.2 AbbVie, Inc Major Business
2.6.3 AbbVie, Inc Graves Disease Treatment Product and Services
2.6.4 AbbVie, Inc Graves Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Mylan N.V
2.7.1 Mylan N.V Details
2.7.2 Mylan N.V Major Business
2.7.3 Mylan N.V Graves Disease Treatment Product and Services
2.7.4 Mylan N.V Graves Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Allergan, plc
2.8.1 Allergan, plc Details
2.8.2 Allergan, plc Major Business
2.8.3 Allergan, plc Graves Disease Treatment Product and Services
2.8.4 Allergan, plc Graves Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Novartis AG
2.9.1 Novartis AG Details
2.9.2 Novartis AG Major Business
2.9.3 Novartis AG Graves Disease Treatment Product and Services
2.9.4 Novartis AG Graves Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Apitope
2.10.1 Apitope Details
2.10.2 Apitope Major Business
2.10.3 Apitope Graves Disease Treatment Product and Services
2.10.4 Apitope Graves Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Amgen INC.
2.11.1 Amgen INC. Details
2.11.2 Amgen INC. Major Business
2.11.3 Amgen INC. Graves Disease Treatment Product and Services
2.11.4 Amgen INC. Graves Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Sun Pharmaceuticals Industries LTD
2.12.1 Sun Pharmaceuticals Industries LTD Details
2.12.2 Sun Pharmaceuticals Industries LTD Major Business
2.12.3 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Product and Services
2.12.4 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Immunovant Inc
2.13.1 Immunovant Inc Details
2.13.2 Immunovant Inc Major Business
2.13.3 Immunovant Inc Graves Disease Treatment Product and Services
2.13.4 Immunovant Inc Graves Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Graves Disease Treatment Breakdown Data by Manufacturer
3.1 Global Graves Disease Treatment Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Graves Disease Treatment Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Graves Disease Treatment
3.4 Market Concentration Rate
3.4.1 Top 3 Graves Disease Treatment Manufacturer Market Share in 2021
3.4.2 Top 6 Graves Disease Treatment Manufacturer Market Share in 2021
3.5 Global Graves Disease Treatment Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Graves Disease Treatment Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Graves Disease Treatment Market Size by Region
4.1.1 Global Graves Disease Treatment Sales in Volume by Region (2017-2028)
4.1.2 Global Graves Disease Treatment Revenue by Region (2017-2028)
4.2 North America Graves Disease Treatment Revenue (2017-2028)
4.3 Europe Graves Disease Treatment Revenue (2017-2028)
4.4 Asia-Pacific Graves Disease Treatment Revenue (2017-2028)
4.5 South America Graves Disease Treatment Revenue (2017-2028)
4.6 Middle East and Africa Graves Disease Treatment Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Graves Disease Treatment Sales in Volume by Type (2017-2028)
5.2 Global Graves Disease Treatment Revenue by Type (2017-2028)
5.3 Global Graves Disease Treatment Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Graves Disease Treatment Sales in Volume by Application (2017-2028)
6.2 Global Graves Disease Treatment Revenue by Application (2017-2028)
6.3 Global Graves Disease Treatment Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Graves Disease Treatment Sales by Type (2017-2028)
7.2 North America Graves Disease Treatment Sales by Application (2017-2028)
7.3 North America Graves Disease Treatment Market Size by Country
7.3.1 North America Graves Disease Treatment Sales in Volume by Country (2017-2028)
7.3.2 North America Graves Disease Treatment Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Graves Disease Treatment Sales by Type (2017-2028)
8.2 Europe Graves Disease Treatment Sales by Application (2017-2028)
8.3 Europe Graves Disease Treatment Market Size by Country
8.3.1 Europe Graves Disease Treatment Sales in Volume by Country (2017-2028)
8.3.2 Europe Graves Disease Treatment Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Graves Disease Treatment Sales by Type (2017-2028)
9.2 Asia-Pacific Graves Disease Treatment Sales by Application (2017-2028)
9.3 Asia-Pacific Graves Disease Treatment Market Size by Region
9.3.1 Asia-Pacific Graves Disease Treatment Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Graves Disease Treatment Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Graves Disease Treatment Sales by Type (2017-2028)
10.2 South America Graves Disease Treatment Sales by Application (2017-2028)
10.3 South America Graves Disease Treatment Market Size by Country
10.3.1 South America Graves Disease Treatment Sales in Volume by Country (2017-2028)
10.3.2 South America Graves Disease Treatment Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Graves Disease Treatment Sales by Type (2017-2028)
11.2 Middle East & Africa Graves Disease Treatment Sales by Application (2017-2028)
11.3 Middle East & Africa Graves Disease Treatment Market Size by Country
11.3.1 Middle East & Africa Graves Disease Treatment Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Graves Disease Treatment Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Graves Disease Treatment and Key Manufacturers
12.2 Manufacturing Costs Percentage of Graves Disease Treatment
12.3 Graves Disease Treatment Production Process
12.4 Graves Disease Treatment Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Graves Disease Treatment Typical Distributors
13.3 Graves Disease Treatment Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer